CSF1R marker enables study of Macrophage Activation Mosaicism

FHS
June 26, 2024
2:32 pm

Macrophages play a critical role in the immune system by fighting infections and aiding in tissue repair.

Digital health deals rallied in the first half of 2024, though funding still trails last year

Digital health startups raised $5.7 billion in the first half of 2024, slightly less than the $6.1 billion in the same period in 2023, according

July 9, 2024

MAINZ BIOMED ESTABLISHES PHYSICIAN-LED LABORATORY EXPANDING SERVICE OFFERING FOR PRIVATELY INSURED PATIENTS IN GERMANY – Biotech Investments

Issuer: Mainz BioMed N.V. / Key word(s): Miscellaneous 06.02.2024 / 14:01 CET/CEST The issuer is solely responsible for the content of this announcement. MAINZ BIOMED

February 7, 2024

Investigating the efficacy and safety of existing drugs in patients with rare immune diseases

This month the first study within the DRIMID consortium (DRIMID stands for Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases) has started.

April 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.